Screener
Castle Biosciences CSTL Total Assets
Total Assets at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Castle Biosciences’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031263
| ASSETS | March 31, 2026 / (unaudited) | December 31, 2025 |
|---|---|---|
| Operating lease assets | 14,424 | 14,795 |
| Goodwill and other intangible assets, net | 97,347 | 99,574 |
| Other assets – long-term | 4,278 | 3,769 |
| Total assets | $547,805 | $578,556 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current Liabilities | ||
| Accounts payable | $15,038 | $18,711 |
| Accrued compensation | 19,111 | 38,287 |
Item 1. Financial Statements.
FAQ
- What is Castle Biosciences's total assets?
- Castle Biosciences (CSTL) reported total assets of $547.81M in Q1 2026.
- How has Castle Biosciences's total assets changed year-over-year?
- Castle Biosciences's total assets increased by 9.2% year-over-year, from $501.72M to $547.81M.
- What is the long-term trend for Castle Biosciences's total assets?
- Over 5 years (2020 to 2025), Castle Biosciences's total assets has grown at a 5.7% compound annual growth rate (CAGR), from $439.33M to $578.56M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Castle Biosciences's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude